Cargando…
Analysis of the efficacy and tolerability of FOLFIRINOX chemotherapy treatment in patients over 65 years of age with diagnosis of advanced adenocarcinoma of the pancreas
INTRODUCTION: Systemic treatment of pancreatic adenocarcinoma in the population of people over 65 years old is a challenge resulting from both the extremely unfavourable prognosis of this cancer and the particularly high sensitivity to the toxicity of chemotherapy in the elderly. This article presen...
Autores principales: | Domagała-Haduch, Małgorzata, Robek, Amanda, Wnuk, Jakub, Michalecki, Łukasz, Gisterek, Iwona |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10230235/ https://www.ncbi.nlm.nih.gov/pubmed/37266343 http://dx.doi.org/10.5114/wo.2023.127013 |
Ejemplares similares
-
Clinical Value of Circulating miRNA in Diagnosis, Prognosis, Screening and Monitoring Therapy of Pancreatic Ductal Adenocarcinoma—A Review of the Literature
por: Wnuk, Jakub, et al.
Publicado: (2023) -
Successful Salvage Chemotherapy with FOLFIRINOX for Recurrent Mixed Acinar Cell Carcinoma and Ductal Adenocarcinoma of the Pancreas in an Adolescent Patient
por: Pfrommer, Sarah, et al.
Publicado: (2013) -
Induction Chemotherapy With FOLFIRINOX Followed by Chemoradiation
With Gemcitabine in Patients With Borderline-Resectable Pancreatic Ductal
Adenocarcinoma
por: Acuna-Villaorduna, Ana, et al.
Publicado: (2022) -
Nab-paclitaxel and gemcitabine or FOLFIRINOX as first-line treatment in patients with unresectable adenocarcinoma of the pancreas: does sequence matter?
por: Vogl, Ursula M., et al.
Publicado: (2019) -
A resected case of acinar cell carcinoma of the pancreas with liver metastasis following chemotherapy using modified FOLFIRINOX
por: Yamada, Shuhei, et al.
Publicado: (2023)